Sonendo, Inc. (“Sonendo”), a leading dental innovation company and creator of the GentleWave® System, announced today that it has launched the roadshow for the first public offering of its common shares. Sonendo is distributing 7,800,000 shares of its common stock. Sonendo also plans to provide the underwriters a 30-day option to purchase up to 1,170,000 additional shares of its common stock. In line with the share, the preliminary public presentation rate is expected to be between $15.00 and $17.00. The equities are expected to trade under the symbol “SONX” on the New York Stock Exchange.
As joint lead book-walking managers and representatives for the planned transaction, BofA Securities, Goldman Sachs & Co. LLC, and Piper Sandler & Co. are acting. Stifel, Nicolaus & Company, Incorporated is also serving as the suggested presentation’s book-walking supervisor. A prospectus may make the presentation more effective. While copies of the initial prospectus relating to this presentation are still available, they can be obtained from: BofA Securities, NC1-004-03-43, two hundred North College Street, third Floor, Charlotte, NC 28255-0001, Attn: Prospectus Department, or by electronic mail at dg.prospectus firstname.lastname@example.org; Goldman Sachs & Co. LLC, two hundred West Street, New York, NY 10282, Attn: Prospectus Department
A registration announcement relating to such securities was filed with the Securities and Exchange Commission in the United States, but it has now expired. These securities cannot be purchased, nor can offers to buy them be made public, until the registration announcement becomes effective. This press release does not constitute an offer to sell or a solicitation of an offer to buy those securities, nor does it constitute a sale of those securities in any nation or jurisdiction where such an offer, solicitation, or sale would be illegal prior to registration or qualification under the securities laws of that nation or jurisdiction.
Sonendo is a commercial-level scientific generation company focused on preventing tooth decay, the most common ongoing sickness in the world. Sonendo has developed the GentleWave® System, a next-generation platform for preventing tooth decay by cleaning and sanitizing microscopic areas within teeth without the need to remove tooth material. The device employs a patented mechanism of action that combines procedure fluid optimization, broad-spectrum acoustic power, and improved fluid dynamics to debride and disinfect deep parts of the difficult root canal gadget in a far less invasive method that maintains tooth structure.
When compared to traditional root canal treatment, the scientific benefits of the GentleWave System include improved scientific outcomes, such as enhanced cleaning that is independent of root canal complexity and tooth anatomy, low and quick recovery expenses, and little to no post-operative pain. In addition, the GentleWave System can help dental businesses improve their workflow and profitability.
TDO® Software, the creator of widely used endodontic exercise control software program solutions, developed to streamline exercise workflow, is also a subsidiary of Sonendo. TDO Software integrates exercise control, imaging, referral reporting, and CBCT imaging with the GentleWave System, as well as providing integrated verbal dialogue.
Certain comments in this press release are forward-looking statements, including those related to the scheduled preliminary public presentation. Those forward-looking statements were generally based on management’s current expectations, assumptions, estimates, and forecasts. While they believe those expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are merely predictions and are subject to known and unknown risks and uncertainties, which include the risk elements disclosed in the registration announcement on Form S-1 relating to the proposed offering, many of which may be beyond their control.
These forward-looking statements include risks and uncertainties that might cause Sonendo’s actual results, overall performance, or accomplishments to differ materially from any future results, overall performance, or achievements indicated or inferred by those forward-looking statements. Forward-looking statements are most effective when they are made on the day they are made. Readers are advised not to place excessive reliance on forward-searching statements, and Sonendo accepts no obligation and has no intention of replacing or revising any forward-searching statements, whether as a result of new information, future events, or otherwise.
Sonendo, Inc. Announces Launch Of Initial Public Offering | Financial Post. (2021, October 25). financial post.